Oxitone Medical

Company Overview

Snapshot

Founded in May 2010 by Leon Eisen, PhD and Ofer Harpak, Oxitone Medical operates with 1–10 employees. The company has raised $9.2M across 4 funding rounds from 4 investors. In September 2017, the FDA cleared Oxitone's wrist-worn pulse oximeter for remote patient monitoring, marking a significant regulatory milestone.

Business overview

Oxitone Medical develops the Oxitone 1000M pulse oximeter, an FDA-cleared wearable medical device designed for continuous monitoring and automatic flagging of critical medical issues in patients with severe chronic diseases. The device's sensors, placed on the wrist, deliver real-time readings of SpO2, pulse rate, HRV, motion, and skin temperature to the cloud. It provides actionable insights such as hypoxia index, apnea index, activity index, sleep efficiency, and physiological stress. Oxitone Medical focuses on patients with acute respiratory failure, physiological stress, and sleep disorders, serving the Health Tech & Life Sciences sector, particularly in digital healthcare and medical devices.

Strategic signal

In June 2020, Ascom UMS selected Oxitone Medical as a wearable solution for continuous remote monitoring of COVID-19 patients. This partnership validated Oxitone's technology for critical care applications during a global health crisis, signaling its capability to address urgent medical needs and expand its market reach through strategic collaborations.

Company Intelligence Q&A

What is Oxitone Medical's core product?

Oxitone Medical's core product is the Oxitone 1000M pulse oximeter, an FDA-cleared wrist-worn device for continuous monitoring of patients with severe chronic diseases.

When did Oxitone Medical receive FDA clearance for its device?

In September 2017, the FDA cleared Oxitone's wrist-worn pulse oximeter for remote patient monitoring.

Which company selected Oxitone Medical for COVID-19 patient monitoring?

In June 2020, Ascom UMS selected Oxitone Medical as a wearable solution for continuous remote monitoring of COVID-19 patients.

Which investors participated in Oxitone Medical's Seed round?

In March 2013, Oxitone Medical received funding from GE Ventures and Gefen Biomed Investments during its Seed round.

What type of funding did Oxitone Medical receive in January 2015?

In January 2015, Oxitone Medical secured a grant from the Israel Innovation Authority.